(Q38210046)

31 August 2017

1 reference

title

Interferons: biological and clinical effects (English)

1 reference

31 August 2017

Nelson BE

1

1 reference

31 August 2017

Borden EC

series ordinal

2

1 reference

31 August 2017

publication date

1 January 1989

1 reference

Journal of Surgical Oncology

31 August 2017

published in

1 reference

31 August 2017

volume

5

1 reference

31 August 2017

issue

6

1 reference

31 August 2017

page(s)

391-401

1 reference

Interferons and their clinical value

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980050605

Interferons in the treatment of human neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980050605

Interferons: from virus inhibitor to modulator of amino acid and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980050605

Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980050605

Central nervous system toxicity of interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980050605

Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980050605

Relation of cytosolic calcium to the microbicidal activation of blood monocytes by recombinant gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980050605

Effects of recombinant leukocyte interferon (rIFN-alpha A) on tumour growth and immune responses in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980050605

Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980050605

Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980050605

Recombinant DNA human interferon alpha 2 in advanced breast cancer: a phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980050605

Recombinant interferon in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980050605

Human lymphoblastoid interferon in the treatment of advanced epithelial ovarian malignancies: a Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980050605

21 January 2018

Identifiers

DOI

10.1002/SSU.2980050605

1 reference

release_3ljvksgp6jeknds4soz6wcv7ja

31 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3ljvksgp6jeknds4soz6wcv7ja

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference